Berbice Capital Management LLC Makes New Investment in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Berbice Capital Management LLC purchased a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 50 shares of the medical equipment provider’s stock, valued at approximately $26,000.

Several other large investors also recently added to or reduced their stakes in the company. LexAurum Advisors LLC increased its stake in shares of Intuitive Surgical by 11.9% in the fourth quarter. LexAurum Advisors LLC now owns 925 shares of the medical equipment provider’s stock worth $483,000 after acquiring an additional 98 shares during the last quarter. Motive Wealth Advisors bought a new stake in Intuitive Surgical in the fourth quarter worth $224,000. Cornerstone Wealth Management LLC boosted its holdings in Intuitive Surgical by 4.8% in the fourth quarter. Cornerstone Wealth Management LLC now owns 550 shares of the medical equipment provider’s stock worth $287,000 after purchasing an additional 25 shares in the last quarter. Brighton Jones LLC boosted its holdings in Intuitive Surgical by 24.9% in the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock worth $1,916,000 after purchasing an additional 731 shares in the last quarter. Finally, Conway Capital Management Inc. boosted its holdings in Intuitive Surgical by 8.4% in the fourth quarter. Conway Capital Management Inc. now owns 4,951 shares of the medical equipment provider’s stock worth $2,584,000 after purchasing an additional 382 shares in the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Stock Performance

ISRG opened at $582.25 on Friday. The stock has a market capitalization of $207.38 billion, a P/E ratio of 93.06, a P/E/G ratio of 5.19 and a beta of 1.39. The company’s 50-day simple moving average is $544.61 and its two-hundred day simple moving average is $502.64. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on ISRG. Citigroup upped their price target on shares of Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a report on Friday. Leerink Partners upped their price target on shares of Intuitive Surgical from $489.00 to $502.00 in a report on Thursday, October 17th. BTIG Research upped their price target on shares of Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a report on Tuesday, November 26th. Royal Bank of Canada upped their price target on shares of Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a report on Friday, October 18th. Finally, Truist Financial upped their price objective on shares of Intuitive Surgical from $570.00 to $640.00 and gave the company a “buy” rating in a research report on Wednesday, December 18th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $563.67.

Insider Transactions at Intuitive Surgical

In related news, CFO Jamie Samath sold 108 shares of the firm’s stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total value of $58,542.48. Following the completion of the transaction, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at approximately $4,746,819.42. This trade represents a 1.22 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Gary S. Guthart sold 18,151 shares of the firm’s stock in a transaction on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the completion of the transaction, the chief executive officer now directly owns 24,219 shares of the company’s stock, valued at approximately $12,391,166.97. This trade represents a 42.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 42,475 shares of company stock worth $22,070,807 in the last quarter. Company insiders own 0.90% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.